Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/21/2012CN102786582A Tem8 peptides and vaccines comprising the same
11/21/2012CN102786575A Diosgenin-3-derivative as well preparation method and application thereof
11/21/2012CN102786538A Salicylaldehyde glycine Schiff base and o-phenanthroline copper (II) coordination compound and preparation process and application thereof
11/21/2012CN102786535A Polymerization aaptamine alkaloid compounds, preparation method thereof and application of polymerization aaptamine alkaloid compounds
11/21/2012CN102786518A Palmatine hydrochloride crystal B substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786512A N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and application thereof to tumor resistance
11/21/2012CN102786509A 2-(5,6-methylxanthone-4-yl)-acetic acid derivatives, preparation method and uses thereof
11/21/2012CN102786493A 2,3-diaryl thiazolidinone compound and analogue, and purpose thereof in preparing antiangiogenic drugs
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102786469A O-pyridylhydrazide derivatives, and preparation method, medicinal composition and uses thereof
11/21/2012CN102786464A Ftibamzone derivative and preparation method and application thereof
11/21/2012CN102786458A Pyrrole formamide derivative, and preparation method and application thereof
11/21/2012CN102786454A Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof
11/21/2012CN102786434A Acetaminophen acid derivative, preparation method and application thereof
11/21/2012CN102786432A Acetaminophen ester derivative, preparation process and purposes of acetaminophen ester derivative
11/21/2012CN102786418A Chlorogenic acid crystal II characterization and preparation methods, and applications of chlorogenic acid crystal II in medicines and healthcare products
11/21/2012CN102786417A Chlorogenic acid crystal III characterization and preparation methods, and applications of chlorogenic acid crystal III in medicines and healthcare products
11/21/2012CN102786394A Substituent bis-aryl methylene naphthenic base derivative as well as preparation method and application thereof
11/21/2012CN102784399A Tumor suppressor gene NDRG2 based application for improving breast cancer chemotherapy sensibility
11/21/2012CN102784398A Composition comprising endostatin adopted as delivery system and chemically-synthesized RNA interference molecule, and application thereof
11/21/2012CN102784397A Method for loading doxorubicine (DOX) anti-cancer medicine by laponite (LAP) clay nanoparticles
11/21/2012CN102784395A Application of MAPK-ERK1/2 signal channel inhibitor to preparation of double-minute medicine for removing or inhibiting tumor cells
11/21/2012CN102784393A Use of Toll-like receptor 5 (TLR5) agonist stFla in anti-pulmonary fibrosis
11/21/2012CN102784384A Application of combination of low-dose naltrexone and methionine-enkephalin to preparation of anti-cancer drug
11/21/2012CN102784363A Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof
11/21/2012CN102784316A Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method
11/21/2012CN102784315A Chinese patent medicine for treating chronic myeloid leukemia
11/21/2012CN102784284A Preparation method of sugar-free oral liquid with anti-cancer effect
11/21/2012CN102784276A Plant extract with anti-tumor effect
11/21/2012CN102784264A Anticancer preparation
11/21/2012CN102784244A Externally applied traditional Chinese medicine for treating breast lumps
11/21/2012CN102784238A Application of drug composition in drug preparation for preventing or treating neovascular diseases
11/21/2012CN102784206A Niweikang and preparation method thereof
11/21/2012CN102784200A Method for extracting lignans from camphor tree leaves
11/21/2012CN102784195A Method for extracting anti-tumor active component from traditional Chinese medicine pericarpium juglantis
11/21/2012CN102784183A Preparation method of red ginseng polysaccharide extract product
11/21/2012CN102784182A Preparation method of Radix Ginseng Rubra polysaccharide extract product
11/21/2012CN102784181A Preparation method of red ginseng polysaccharide
11/21/2012CN102784176A Method for preparing taxad leaves and application of taxad leaves in preparing anticancer drugs
11/21/2012CN102784175A Tricholoma mongolicum liquid fermentation and antitumor activity of fermented products
11/21/2012CN102784174A Process for preparing Chinese caterpillar fungus micropowder and preparation thereof
11/21/2012CN102784164A Application of polysaccharide sulphate to preparation of tumor treatment neovascularization inhibitors and vascular disrupting agents
11/21/2012CN102784134A Application of aromatic acid derivative with nitric oxide donor in preparation of medicines for treating malignant cancers
11/21/2012CN102784114A Bortezomib freeze-dried powder injection and preparation method thereof
11/21/2012CN102784112A Preparation method for porous slow-release microsphere of chitosan graft copolymer
11/21/2012CN102784109A Taxane medicines albumin nanoparticle preparation for injection and preparation method thereof
11/21/2012CN102784107A Gemcitabine or salt liposome thereof, and preparation method and application thereof
11/21/2012CN102784105A RLT polypeptide-mediated docetaxel tumor targeting submicroemulsion and preparation method thereof
11/21/2012CN102784096A Asiatic acid self-microemulsifying drug delivery system and its preparation method
11/21/2012CN102329362B Ursolic acid derivative chemically modified by polyethylene glycol and preparation method of ursolic acid derivative
11/21/2012CN102311956B Specific base modification antisense nucleotide chain and application thereof
11/21/2012CN102309621B Medicament for treating scleromere hyperplasia and use method thereof
11/21/2012CN102276605B Dihydro-pyrazolo hexahydropyridine derivative, preparation method and application thereof
11/21/2012CN102272126B Optical pure quinazoline compounds
11/21/2012CN102266288B Reductive sensitivity tumor target lipidosome based on cholesterol modification
11/21/2012CN102233060B Baihuawang liquid and use thereof
11/21/2012CN102227222B Antitumor agent, method for production of the agent and method for stabilisation thereof
11/21/2012CN102190644B Chiral 3-hydroxypyridin-4-one derivatives, synthesis and application thereof
11/21/2012CN102188717B Self-emulsifying doxorubicin nanometer medicament and preparation method thereof
11/21/2012CN102188439B Nanoparticle liposome for releasing different medicines in programmed manner and preparation and use thereof
11/21/2012CN102178688B Preparation method of ivy saponins ingredient and application of the ingredient to resisting tumors
11/21/2012CN102174469B Method for effectively culturing tumor infiltrating lymphocytes (TILs)
11/21/2012CN102153558B Derivative of multi-target antitumor inhibitor 2-aminopyrrole-triazine and synthesis method thereof
11/21/2012CN102127091B Heterocyclic ring-containing schiff base compound
11/21/2012CN102119937B Application of scorpion venom injection in treatment of cancers
11/21/2012CN102060991B Amphiphilic prodrug of 7- ethyl-10-hydroxycamptothecin and preparation method thereof
11/21/2012CN102030829B Anti-melanoma cytotoxic lymphocyte (CTL) multi-epitope peptide and application thereof
11/21/2012CN102028951B RGDfK-modified oridonin polylactic acid medicament-carrying nanoparticles and preparation method thereof
11/21/2012CN102020649B Diketopiperazine compound as well as composition, preparation method and application thereof
11/21/2012CN101955461B Hsp90 inhibitor Xbj-B11 and preparation method and application thereof
11/21/2012CN101912382B 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
11/21/2012CN101857595B Quinnazolidone derivative, preparation method thereof and purpose of serving as anticarcinogen
11/21/2012CN101827825B Crystalline chemotherapeutic
11/21/2012CN101768219B Recombinant fusion protein and preparing method and application thereof
11/21/2012CN101709058B Polyene macrolides compound, preparation and application thereof
11/21/2012CN101683518B Application of FHL 1 in preparing medicament for treating tumour
11/21/2012CN101664378B Medical composition of recombinant human serum albumin and interferon alpha fusion protein
11/21/2012CN101648902B Dihydropyridine type tumor chemotherapeutic sensitizer and application thereof
11/21/2012CN101624332B New compound with anti-tumor activity and application thereof
11/21/2012CN101569622B Pharmaceutical preparation for injection administration and preparation method thereof
11/21/2012CN101511355B Application of (2Z)-2-(3, 4-dihydroxy bezilidene)-1-benzofuran-3(2H)-ketone for preparation of anti-cancer medicine
11/21/2012CN101487009B Method for preparing vaccine for anti-HPV 16 infection by pichia yeast expression system
11/21/2012CN101484443B Potentiator of radiation therapy
11/21/2012CN101466409B Leptomycin derivatives
11/21/2012CN101422425B Etretinate type medicine solid dispersion
11/21/2012CN101327010B Method for preparing amber ginseng
11/21/2012CN101302199B Guidemycin and use thereof in tumor treatment
11/21/2012CN101245083B Platinum complex containing 1,3-dioxolane structure, synthesizing process and uses thereof
11/21/2012CN101189258B A peptide ligand to impair cancer cell migration
11/21/2012CN101088502B Mixture solution containing conjugate of transferrin and quercetin and use thereof
11/21/2012CN101039663B STAT3 phosphorylation inhibitor and notch 1 expression inhibitor
11/21/2012CN101018783B Quinoxaline inhibitors of the HEDGEHOG signalling pathway
11/21/2012CN101003556B Derivative of 10 - hydroxyl camptothecin, prepartion of liposome thereof, and preparation method
11/20/2012US8314234 Bicyclic pyrimidine kinase inhibitors
11/20/2012US8314230 Cyclodextrin-based polymers for therapeutics delivery
11/20/2012US8314109 6-heterocyclic-imidazo[1,2-α]pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
11/20/2012US8314087 Nitrogen-containing heterocyclyl ketones and methods of use
11/20/2012US8314068 P2X7 inhibition of epithelial cancers and papillomas
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8313913 Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 2211